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ABSTRACT
BACKGROUND AND PURPOSE: Different T1-weighted sequences have been used for qualitative and quantitative evaluation of T1 signal
intensity related to gadolinium deposition in the dentate nucleus in patients who underwent several enhanced MR imaging studies. Our
purposewas to perform an intraindividual qualitative and quantitative comparison between T1-weighted spin-echo and 3Dmagnetization-
prepared rapid acquisition of gradient echo sequences in patients who had multiple exposures to gadodiamide.
MATERIALS ANDMETHODS: Our retrospectively selected population included 18 patients who underwent at least 3 administrations of
gadodiamide and had a baseline and a finalMR imaging performedwith both T1-weighted sequences. Qualitative and quantitative analyses
were independently performed. Dentate nucleus/middle cerebellar peduncle signal-intensity ratios and signal changes between the
baseline and final examinations were compared by using the Wilcoxon signed rank test. Correlation between quantitative and qualitative
evaluations was assessed by using a polyserial correlation test.
RESULTS: The differences between the 2 sequences for both baseline and last examination dentate nucleus/middle cerebellar peduncle
ratios were statistically significant (P .008 and P .006, respectively); however, the signal-intensity changes of the ratios with time were
not (P .64). The correlation between the qualitative and quantitative analysis was very strong (near-perfect) (r 0.9) for MPRAGE and
strong (r 0.63) for spin-echo sequences.
CONCLUSIONS: T1-weighted spin-echo and MPRAGE sequences cannot be used interchangeably for qualitative or quantitative analysis
of signal intensity in the dentate nucleus in patients who received gadodiamide. Baseline and final examination ratios should be evaluated
across time by using the same sequence.Qualitative analysis performedwithMPRAGE correlated betterwith quantitative analysis andmay
offer advantages over spin-echo sequences for research purposes.
ABBREVIATIONS: DN  dentate nucleus; eGFR  estimated glomerular filtration rate; GBCA  gadolinium-based contrast agent; MCP  middle cerebellar
peduncle; SE spin-echo
During the past 2 years, several peer-reviewed studies havebeen published describing an association between progres-
sive high signal intensity on unenhanced T1-weighted images in
the globus pallidus and/or dentate nucleus (DN) and the number
of administrations of different gadolinium-based contrast agents
(GBCAs), suggesting gadolinium deposition in these structures;
this has been confirmed in humans and animals.1-11
One major limitation of retrospective human studies of gado-
linium deposition is the variability of the MR imaging protocols
used, according to the pathology that is being studied and among
different institutions.
Kanda et al5 and Adin et al8 used qualitative measurements to
evaluate signal-intensity changes in patients who underwentmul-
tiple GBCA administrations, by using T1-weighted spin-echo
(SE),5,8 T1 MPRAGE, or T1 FLAIR images.8 It is generally as-
sumed that visual analysis correlates well with quantitative anal-
ysis, but qualitative assessment of the presence or absence of hy-
perintensity on T1-weighted MR images is subjective; hence,
quantitative signal-intensity measurement is commonly favored.
In most of the published literature, the authors have used T1-
weighted SE sequences to quantitatively evaluate the signal inten-
sity and signal changes with time. However, in some studies, dif-
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ferent T1-weighted sequences have been interchangeably used,
including T1-weighted 3DMPRAGE6 and FLASH,12 to quantita-
tively evaluate signal-intensity changes in the dentate nucleus.
Not surprising, the results among different investigators are
somewhat contradictory. The use of different sequences may, in
part, explain these differences.13 It is unclear whether different
T1-weighted sequences may be used interchangeably to qualita-
tively and quantitatively study gadoliniumdeposition on the basis
of their T1-weighting despite their distinct intrinsic properties.
Even though quantitativemeasurements are undoubtedly recom-
mended for scientific publications, they are difficult to apply in
clinical practice. On the other hand, qualitative analysis is applied
every day to assess normal brain structures and lesions. Consid-
ering the increasing concern regarding GBCA administration, we
believe qualitative analysis must be evaluated. Therefore, our aim
was to determine whether there are differences between the quan-
titative analysis performedwith T1-weighted SE and T1-weighted
MPRAGE sequences and to correlate the qualitative appreciation
of the T1 signal intensity of the DN with the quantitative analysis
of corresponding sequences.
MATERIALS AND METHODS
Patients
Institutional review board approval was obtained for this single-
center (University of North Carolina Hospital at Chapel Hill)
retrospective longitudinal observational study with a waiver of
informed consent.
From a data base of subjects with multiple GBCA administra-
tions for brain MR imaging studies, we identified 50 consecutive
patients who underwent at least 2 brain contrast-enhanced stud-
ies performed with gadodiamide (Omniscan; GEHealthcare, Pis-
cataway, New Jersey) plus an additional last MR imaging for
reference. Our center used gadodiamide (Omniscan) for all en-
hanced MR imaging studies performed before December 2006,
irrespective of the patient’s renal function. From December 2006
to June 2007, patients with normal renal function received gado-
diamide (Omniscan), and after June 2007, the use of gadodiamide
(Omniscan) was discontinued. All MR imaging examinations
were performed as clinical studies. Because gadodiamide (Omnis-
can) was the only contrast evaluated, only studies performed be-
fore June 2007 were included. Evaluation of medical records per-
mitted exclusion of patients who had undergone contrast agent
administration outside our institution orwhohad undergoneMR
imaging with a GBCA other than gadodiamide (Omniscan). Pa-
tients with abnormal liver or renal function were also excluded.
Abnormal liver function was defined by abnormal serum concen-
trations of aspartate aminotransferase, alanine aminotransferase,
total bilirubin, or g-glutamyl transpeptidase. Renal function was
evaluated by calculating the estimated glomerular filtration rate
(eGFR) and was classified as normal (eGFR  60 mL/min/m2),
moderately abnormal (eGFR between 30 and 60 mL/min/m2), or
severely insufficient (eGFR 30 mL/min/m2).
Among the 50 patients selected, only those who had a first
baselineMR imaging and a lastMR imaging performed with both
T1-weighted SE and 3D MPRAGE sequences were included for
analysis (Fig 1). Thus, our final population included 18 patients
(12 women, 6 men; mean age, 52.56  15.21 years). The total
number of administered doses of GBCA ranged from 2 to 10
(mean, 4.78  2.51 doses), and the interval between the first
and last examinations ranged from 96 to 1905 days (mean,
933 610.78 days). A summary of patient data is shown in the
Table.
Imaging Protocols
MR imaging was performed by using a 1.5T MR imaging unit
(Magnetom Avanto; Siemens, Erlangen, Germany) with a 12-el-
ement designed headmatrix coil. TheMR imaging protocols var-
ied according to the clinical indications but included, in all pa-
tients, a fast spin-echo T1-weighted sequence (TR, 623ms; TE, 13
ms; echo-train length, 1; section thickness, 5 mm; spacing, 1 mm;
matrix size, 256 256; and FOV, 165 220) and a T1-weighted
3DMPRAGE sequence (TR, 1740 ms; TE, 3.45 ms; section thick-
ness, 1.0 mm; matrix size, 256  256; FOV, 250 mm) before
GBCA injection. A standard dose of 0.1mmol of gadodiamide per
kilogram of bodyweight was administered intravenously by using
FIG 1. AxialMR images in a 40-year-oldmale patientwith a right frontal low-grade astrocytoma. Unenhanced axial T1-weighted spin-echo (A and
C) and 3DMPRAGEMR images (B and D) of the first (A and B) and fifth (2 years later, C and D) gadolinium-enhancedMR imaging examinations at
the level of the dentate nuclei of the cerebellum. The images show progressively increased T1 signal of the dentate nuclei (white arrows, C and
D). Note that the qualitative analysis was slightly different between the 2 sequences.
Patients’ demographic and clinical characteristics
Demographics
Patients (number) 18
Sex 12Women
Age (mean SD) (range) (yrs) 52.56 15.21 (17–76)
eMRIs performed (mean SD)
(range)
4.78 2.51 (2–10)
Interval (MRIbaselineMRIx)
(mean SD) (range)
933 610.78 (96–1905 days)
Diagnosis (number)
Meningioma 12
Glioblastoma 2
Low-grade glioma 1
Oligodendroglioma 1
Chordoma 1
Spinal hemangioblastoma 1
Note:—eMRI indicates enhanced MR imaging; yrs, years.
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a power injector (Spectris Solaris EP; Medrad, Indianola, Penn-
sylvania) at a rate of 1.5–2.0 mL/s, followed by a 20-mL saline
flush bolus administered at the same rate.
Imaging and Data Analysis
For each patient, the number of gadolinium-enhancedMR imag-
ing examinations performed with gadodiamide was recorded.
Both sequences, T1-weighted SE and 3D MPRAGE, in the first
(MRIbaseline) and last (MRIx, with x being the number of the con-
trast-enhanced MR imaging studies) examinations were quanti-
tatively and qualitatively analyzed. Two neuroradiologists, who
were blinded to clinical data, independently reviewed all images
on a dedicated workstation (Impax, Version 6; Agfa-Gevaert,
Mortsel, Belgium). Disagreements were resolved by consensus.
Qualitative Analysis
Signal intensity in the DN on unenhanced T1-weighted images
was classified by comparison with the signal intensity of the cen-
tral normal-appearing white matter of the cerebellum by using a
previously described and widely used 4-point grading scale,14 in
which grade 4 indicates prominent hyperintensity; grade 3, faint
hyperintensity; grade 2, isointensity; and grade 1, hypointensity.
When visible, the DNwas defined as an irregularly folded ribbon-
like structure located in the medial deep white matter of each
cerebellar hemisphere. Variable window and level settings were
used when reviewing the MR images.15
Quantitative Analysis
Oval ROIs were placed on theDN andmiddle cerebellar peduncle
(MCP) on both sides to include as much of each anatomic struc-
ture as possible, avoiding lesions, vessels, or artifacts. When the
DN was unclear on T1-weighted images, the same section posi-
tion on T2-weighted images was used to guide ROI placement.
Measurements were averaged for both the right and left sides and
for both readers. The DN/MCP signal-intensity ratio was calcu-
lated by dividing themean signal intensity of theDNby that of the
MCP.
Statistical Analysis
R: A Language and Environment for Statistical Computing (R
Core Team; Vienna, Austria)16 was used for all statistical comput-
ing. Statistical significance was defined as a P .05.
Interobserver agreement between the 2 readers’ ROImeasure-
ments for each structure was evaluated by using the Lin concor-
dance correlation coefficient,17 grouped by structures for both
sides. The strength of the agreement was considered near-perfect
when it was0.99, substantial when it was 0.95–0.99, moderate
when it was 0.90–0.95, and poor when it was 0.90. Interob-
server agreement is illustrated by using Bland-Altman plots (dif-
ference plots) (Fig 2).
Interobserver agreement for qualitative data was assessed by
using kappa statistics, grouped by structures for both sides, as per
the Landis andKoch schema. Conventionally,  0 is considered
poor agreement; 0.01–0.20, slight; 0.21–0.40, fair; 0.41–0.60,
moderate; 0.61–0.80, substantial; and 0.81–1.00, near-perfect
agreement.
DN/MCP ratios, averaged for both readers for the baseline and
final examinations, were calculated for both sequences and com-
pared by using the Wilcoxon signed rank test. This test was also
used to evaluate significant differences in change with time in
signal-intensity ratios for both sequences.
Correlation between DN/MCP ratios and qualitative signal
evaluation of theDN, for both baseline and last examinations, was
assessed by using a polyserial correlation test. The strength of
correlation was perfect if r  1; very strong, r  0.70; strong,
0.40 r 0.69;moderate, 0.30 r 0.39; weak, 0.20 r 0.29;
and no or negligible relationship, 0.01 r 0.19.
RESULTS
Each reader drew 280 ROIs. The left DN andMCP were not mea-
sured in 1 patient due to disease involvement. In this patient, the
analysis was performed by using only the right-sided structures.
Interobserver agreement was near-perfect for both evaluated
structures: for the DN, it was 0.998 (95% confidence interval,
A
B
FIG 2. Bland-Altman plots show the differences in average ROI mea-
surements between the 2 readers for the dentate nucleus (A) and
middle cerebellar peduncle (B).
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0.997–0.999), and for the MCP, it was 0.999 (95% confidence
interval, 0.998–0.999).
For qualitative analysis, interobserver agreement was also
near-perfect,   0.899. Among the 72 evaluations (4 exami-
nations for each patient: SE MRIbaseline, SE MRIx, MPRAGE
MRIbaseline, and MPRAGEMRIx), there were 16 disagreements
solved by consensus.
The differences between the 2 sequences for both baseline and
last examination DN/MCP ratios were statistically significant
(P  .008 and P  .006, respectively) (Fig 3), but the change in
ratio with time was not (P .64).
The correlation between the qualitative and quantitative anal-
ysis was very strong (near-perfect) (r 0.9) for theMPRAGE and
strong for the SE sequence (r 0.63) (Fig 4).
DISCUSSION
Our results showed that the DN/MCP signal-intensity ratios were
significantly different and overall higher with the SE than the
MPRAGE sequence. The change with time between the first and
last examination for each sequence was not significantly different.
The correlation between the qualitative and quantitative evalua-
tions was near-perfect for the MPRAGE sequence and strong for
the SE sequence.
Significant differences were found comparing the DN/MCP
ratios between the 2 sequences, which we consider an indication
that these 2 sequences should not be used interchangeably. Both
sequences showed similar signal-intensity progression with time
but different signal-intensity ratios at the baseline and last exam-
inations. The performance of both sequences for quantitative
evaluations of the T1-weighted signal-intensity changes in theDN
was also similar.
Radbruch et al6 used both T1-weighted sequences for signal-
intensity quantification of the DN. In their study, it was not clear
whether the ROI measurements between the first and last exam-
inations were performed by using the same sequence. Our find-
ings suggest that comparing different sequences between studies
may generate inaccurate results. Furthermore, for statistical pur-
poses, the change in signal intensity between the first and last
examinations is better than the ratios. Adin et al8 also appeared to
have used SE and MPRAGE interchangeably, and on the basis of
our results, we consider that a substantial limitation in their study.
Theoretically, our results are to be expected because SE and
MPRAGE sequences are different in nature. SE imaging is a 2D
acquisition technique in which short TRs and TEs produce T1-
weighted images in which tissue contrast is primarily related to
differences in the T1 relaxation time of each tissue.18 MPRAGE is
a T1-weighted 3D sequence acquiredwith a 3D Fourier transform
technique following a magnetization-prepared 180° inversion
pulse. The use of an inversion pulse allows greater T1 contrast
compared with SE imaging; however, the T1-weighting of differ-
ent tissues may be considerably different between structures, de-
pending on the selected TI. Signal-to-noise ratios and contrast-
to-noise ratios are greater with SE compared with MPRAGE, and
the inherently high signal intensity of white matter may account
for the lower DN/MCP ratio signal intensity, as seen in our study,
because the MCP is a white matter structure.18,19 Substantial
changes of parameters of the same imaging sequence used can
render the comparisons of that sequence inaccurate. However, we
believe that because those parameters have been preset, in a way,
to avoid tangible changes across systems of the same field strength
at our institution, the comparison would be less affected com-
pared with the use of completely different imaging pulse
sequences.
Our results suggest that qualitative evaluation ismore accurate
with MPRAGE than with the SE sequence. The stronger correla-
tion between qualitative and quantitative analysis with MPRAGE
may be explained by the greater gray/whitematter contrast inher-
FIG 3. Intraindividual linear graphic representation of the DN/MCP
ratios, with error bars, for spin-echo and 3D MPRAGE sequences.
Note the higher ratios with SE on both baseline and final
examinations.
FIG 4. Intraindividual linear graphic representation demonstrating
the correlation between qualitative and quantitative (DN/MCP ratio)
evaluations of the increased T1 signal intensity within the dentate
nucleus for SE and 3D MPRAGE sequences. Note the stronger corre-
lation with MPRAGE (0.9) compared with SE (0.63). Values on the
y-axis are represented on an ordinal scale with random vertical offset
(jitter) to minimize overlapping.
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ent to this sequence compared with SE. This likely reflects the
greater T1-weighted contrast of the MPRAGE sequence achieved
by the initial 180° inversion pulse.20
Limitations of our study include the retrospective nature of
data acquisition and the small sample size; the strict inclusion
criteria limited the sample size of our study. However, we believe
that the pair-wise comparison nature of our study compensates
for the small sample size. Another possible limitation is the use of
theMCP, a white matter structure, as the denominator in the DN
ratios because the relative signal intensity of the white matter is
higher on the MPRAGE sequence. Because research into the sub-
ject of brain deposition is still relatively new, it is still unclear
which is the best reference structure for the DN ratio calculation.
As previously performed,4 we calculated the ratio by using the
MCP instead of the base of the pons2,3,6 because the latter may
exhibit heterogeneous signal intensity related to presumed vascu-
lar changes. Additionally, Radbruch et al6,21 reported that the
ratios of the DN with the pons, cerebellum, and CSF were com-
parable. Thus, no significant differences for the DN/MCP signal-
intensity ratio should be expected.
CONCLUSIONS
T1-weighted SE and MPRAGE sequences should not be used in-
terchangeably for qualitative or quantitative T1 signal-intensity
analysis of the DN in patients who undergo several contrast-
enhanced MR imaging studies because they are fundamentally
different sequences, despite their similar appearance. Both se-
quences generate similar performance in quantitative analysis on
an individual basis. Baseline and final examination ratios should
be evaluated by using the same sequence across time, and differ-
ences in ratios between the baseline and final examination should
be evaluated instead of ratio signal intensity at specific time
points.Qualitative analysis is better performedwith theMPRAGE
sequence, reflecting its intrinsic higher gray–white matter con-
trast. This sequence seems to be a promising simple screening tool
to be used in clinical practice for evaluating patients withmultiple
administrations of GBCA and may offer advantages over SE se-
quences for research purposes.
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